BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18993168)

  • 1. The relationship of endometriosis and ovarian malignancy: a review.
    Nezhat F; Datta MS; Hanson V; Pejovic T; Nezhat C; Nezhat C
    Fertil Steril; 2008 Nov; 90(5):1559-70. PubMed ID: 18993168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
    Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
    Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Implications for Patients with Endometriosis.
    Wilbur MA; Shih IM; Segars JH; Fader AN
    Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endometriosis-associated ovarian cancers: pathogenesis and consequences on daily practice].
    Borghese B; Santulli P; Vaiman D; Alexandre J; Goldwasser F; Chapron C
    J Gynecol Obstet Biol Reprod (Paris); 2013 Jun; 42(4):325-33. PubMed ID: 23578493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
    Munksgaard PS; Blaakaer J
    Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
    Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
    Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Mutations in Endometriosis: Link to Ovarian Cancer.
    Bulun SE; Wan Y; Matei D
    Endocrinology; 2019 Mar; 160(3):626-638. PubMed ID: 30657901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
    Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
    Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer in endometriosis: an update on the clinical and molecular aspects.
    Ruderman R; Pavone ME
    Minerva Ginecol; 2017 Jun; 69(3):286-294. PubMed ID: 28271698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Sep; 30(9):612-7. PubMed ID: 24905724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
    Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
    Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential scenarios leading to ovarian cancer arising from endometriosis.
    Kobayashi H
    Redox Rep; 2016 May; 21(3):119-26. PubMed ID: 26317761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular changes in endometriosis-associated ovarian clear cell carcinoma.
    Worley MJ; Liu S; Hua Y; Kwok JS; Samuel A; Hou L; Shoni M; Lu S; Sandberg EM; Keryan A; Wu D; Ng SK; Kuo WP; Parra-Herran CE; Tsui SK; Welch W; Crum C; Berkowitz RS; Ng SW
    Eur J Cancer; 2015 Sep; 51(13):1831-42. PubMed ID: 26059197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
    Van Gorp T; Amant F; Neven P; Vergote I; Moerman P
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):349-71. PubMed ID: 15157647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.
    Siufi Neto J; Kho RM; Siufi DF; Baracat EC; Anderson KS; Abrão MS
    J Minim Invasive Gynecol; 2014; 21(1):55-63. PubMed ID: 23962574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that endometriosis behaves in a malignant manner.
    Thomas EJ; Campbell IG
    Gynecol Obstet Invest; 2000; 50 Suppl 1():2-10. PubMed ID: 11093055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
    Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
    Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
    del Carmen MG
    Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.